Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.

McPhail S, Barclay ME, Johnson SA, Swann R, Alvi R, Barisic A, Bucher O, Creighton N, Denny CA, Dewar RA, Donnelly DW, Dowden JJ, Downie L, Finn N, Gavin AT, Habbous S, Huws DW, May L, McClure CA, Møller B, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Shack L, Tian X, Thomas RJS, Thomson CS, Wang H, Woods RR, You H, Lyratzopoulos G, ICBP Module 9 Chemotherapy Group

Open source

DOI
10.1016/s1470-2045(24)00031-7
Published
2024 Mar
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00031-7,
  title = {Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.},
  author = {McPhail S and Barclay ME and Johnson SA and Swann R and Alvi R and Barisic A and Bucher O and Creighton N and Denny CA and Dewar RA and Donnelly DW and Dowden JJ and Downie L and Finn N and Gavin AT and Habbous S and Huws DW and May L and McClure CA and Møller B and Musto G and Nilssen Y and Saint-Jacques N and Sarker S and Shack L and Tian X and Thomas RJS and Thomson CS and Wang H and Woods RR and You H and Lyratzopoulos G and ICBP Module 9 Chemotherapy Group},
  year = {2024},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(24)00031-7},
  url = {https://doi.org/10.1016/s1470-2045(24)00031-7}
}

RIS

TY  - JOUR
TI  - Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
AU  - McPhail S
AU  - Barclay ME
AU  - Johnson SA
AU  - Swann R
AU  - Alvi R
AU  - Barisic A
AU  - Bucher O
AU  - Creighton N
AU  - Denny CA
AU  - Dewar RA
AU  - Donnelly DW
AU  - Dowden JJ
AU  - Downie L
AU  - Finn N
AU  - Gavin AT
AU  - Habbous S
AU  - Huws DW
AU  - May L
AU  - McClure CA
AU  - Møller B
AU  - Musto G
AU  - Nilssen Y
AU  - Saint-Jacques N
AU  - Sarker S
AU  - Shack L
AU  - Tian X
AU  - Thomas RJS
AU  - Thomson CS
AU  - Wang H
AU  - Woods RR
AU  - You H
AU  - Lyratzopoulos G
AU  - ICBP Module 9 Chemotherapy Group
PY  - 2024
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(24)00031-7
UR  - https://doi.org/10.1016/s1470-2045(24)00031-7
ER  - 

APA

S, M., ME, B., SA, J., R, S., R, A., A, B., O, B., N, C., CA, D., RA, D., DW, D., JJ, D., L, D., N, F., AT, G., S, H., DW, H., L, M., CA, M., B, M., G, M., Y, N., N, S., S, S., L, S., X, T., RJS, T., CS, T., H, W., RR, W., H, Y., G, L., & Group, I. M. 9. C. (2024). Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00031-7

Source records